Clinical trials: Mecamylamine
Autistic Disorder, Pervasive Developmental Disorder
Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders
The purpose of this study is to examine the safety and efficacy of mecamylamine for the core symptoms of autism.
- Trial name
- NCT00773812
- Testing
- mecamylamine
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Ohio State University